financetom
Business
financetom
/
Business
/
High Tide Closes Acquisition of a Majority Stake in Remexian Pharma GmbH
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
High Tide Closes Acquisition of a Majority Stake in Remexian Pharma GmbH
Sep 2, 2025 4:18 AM

06:51 AM EDT, 09/02/2025 (MT Newswires) -- Cannabis retailer High Tide Inc. ( HITI ) , trading shy of 52 week highs in Canada and the United States, on Tuesday announced that it has completed the acquisition of a 51% interest in Remexian for an estimated purchase price of 26.4 million euros,

A statement noted the purchase price will be finalized in 30 days, once the final closing balance sheet is available, and the deal will include a five-year option to buy the remaining 49% of Remexian at any time after 24 months.

"Today marks a transformational moment in High Tide's journey as we officially plant our flag in Europe. With the closing of this majority acquisition of Remexian, High Tide is no longer just a Canadian success story, we are now a global cannabis company with real scale in Europe's largest federally regulated market," said Raj Grover, Founder and Chief Executive Officer of High Tide.

"This transaction not only diversifies our revenue base beyond Canada but also creates a clear runway for expansion across Europe's regulated cannabis markets. With our proven track record of disciplined growth and free cash flow generation, we believe this acquisition positions High Tide for long-term global leadership."

HITI was up 0.4% in Canada last Friday, before the Labor Day holiday weekend.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
MainStreet Bancshares Shares Fall After Lower Q2 Results
MainStreet Bancshares Shares Fall After Lower Q2 Results
Jul 29, 2024
01:24 PM EDT, 07/29/2024 (MT Newswires) -- MainStreet Bancshares ( MNSB ) shares were down 3.5% in recent trading after the company reported Q2 earnings Monday of $0.27 per diluted share, down from $0.85 a year earlier. Two analysts polled by Capital IQ expected $0.29. Revenue for the quarter ended June 30, expressed as the sum of net interest income...
Novartis Gets US FDA's Priority Review for Chronic Myeloid Leukemia Drug
Novartis Gets US FDA's Priority Review for Chronic Myeloid Leukemia Drug
Jul 29, 2024
01:24 PM EDT, 07/29/2024 (MT Newswires) -- Novartis ( NVS ) said Monday it has received priority review from the US Food and Drug Administration for Scemblix as a potential treatment for Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase in newly diagnosed adult patients. The FDA's priority review designation is based on the results of a phase 3 study,...
Hedge funds sweeten takeover bid for energy firm Martin Midstream, letter says
Hedge funds sweeten takeover bid for energy firm Martin Midstream, letter says
Jul 29, 2024
NEW YORK, July 29 (Reuters) - Hedge funds Nut Tree Capital Management and Caspian Capital have made a sweetened bid to acquire fuels storage and transporter Martin Midstream Partners ( MMLP ), according to a letter seen by Reuters on Monday. The new offer would give unitholders of Martin Midstream ( MMLP ) $4.50 per unit in cash and value...
Eyenovia Shares Fall After Regaining Compliance With Nasdaq Minimum Bid Price Rule
Eyenovia Shares Fall After Regaining Compliance With Nasdaq Minimum Bid Price Rule
Jul 29, 2024
01:13 PM EDT, 07/29/2024 (MT Newswires) -- Eyenovia's ( EYEN ) shares were down 3.8% in recent Monday trading after the company said it regained compliance with Nasdaq's minimum bid price requirement for continued listing. The company said it received the compliance notice from Nasdaq on Friday. Price: 1.39, Change: -0.05, Percent Change: -3.82 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved